Short answer
Health Catalyst, Inc. (HCAT) filed an 8-K current report with the SEC on April 3, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Daniel Burton’s CEO retirement effective February 12, 2026 creates a leadership transition at Health Catalyst.
Health Catalyst, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Daniel Burton’s CEO retirement effective February 12, 2026 creates a leadership transition at Health Catalyst
- Strategic advisor role through December 31, 2026 supports handoff of CEO responsibilities
- Average monthly salary of $10,000 under transition agreement
- Forfeiture of unvested restricted stock units and performance-based units eligible after March 2, 2026
- General release limits potential claims against Health Catalyst tied to his departure
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Health Catalyst, Inc. 8-K filings
Get the next HCAT 8-K as it lands
Follow HCAT for push alerts, or ask the research agent what this filing means.